Sabinsa Europe will be participating in this year’s Nutraceutical Europe event in Barcelona. Sabinsa will showcase, scientifically and clinically studied products as following:

• Curcumin C3 Reduct®: The only EFSA-approved Curcuminoids metabolite on the EU market. It is scientifically demonstrated that most of curcuminoids benefits are attributable to Tetrahydrocurcuminoids. Curcumin C3 Reduct contains 95% Tetrahydrocurcuminoids.
• CIRPUSINS®: Our new, innovative, clinically studied weight management product for healthy weight loss.
• Nigellin® and Saberry®: Additional products that highlight our commitment to offering natural, effective food supplements.

Special Presentation by Dr. Umar Jan

Highlighting our event schedule, Dr. Umar Jan, President of European Operations at Sabinsa, will deliver an insightful presentation on CIRPUSINS. Join us on March 7th at 11:00 AM to delve into the science and innovation behind this groundbreaking product. Don’t miss this opportunity to learn more about how Sabinsa is shaping the way for future health and wellness trend